biohacking$bioLLM CA: TBA

database / hormone

Angiotensin II

approved hormone cardiovascularrenal mass-verified
OOOOOOOOOOOONNNNNNNNNNNNNHHHHHHHHHHHHHHHH
75 heavy atoms · 149 bonds · drag to pan, scroll to zoom C50N13O12

Skeletal structure drawn from the computed atomic coordinates in PubChem CID 172198. Carbons are implicit vertices; hydrogens on carbon are suppressed, as in any structural formula. Nothing here is estimated — every atom sits where PubChem placed it.

Research reference only. The observations below are recorded in the cited literature. Nothing here is advice or a recommendation, and no dosing information is published on this site.

Sequence

DRVYIHPF

Asp-Arg-Val-Tyr-Ile-His-Pro-Phe

1. Asp — Aspartic acid · negative · hydropathy -3.5 · charge −1D12. Arg — Arginine · positive · hydropathy -4.5 · charge +1R3. Val — Valine · hydrophobic · hydropathy 4.2 · charge 0V4. Tyr — Tyrosine · aromatic · hydropathy -1.3 · charge 0Y5. Ile — Isoleucine · hydrophobic · hydropathy 4.5 · charge 0I6. His — Histidine · positive · hydropathy -3.2 · charge 0H67. Pro — Proline · proline · hydropathy -1.6 · charge 0P8. Phe — Phenylalanine · aromatic · hydropathy 2.8 · charge 0F8

Computed backbone mass 1046.19 Da agrees with PubChem's reported 1046.2 Da (Δ 0.01 Da). Two independent sources agree on the primary structure.

Molecular data

Chemical fields come from the PubChem compound record; computed values are derived from the sequence shown above.
molecular formulaC50H71N13O12
molecular weight1046.2 Da (PubChem)
computed backbone mass1046.19 Da
length8 residues
net charge (pH 7.4)0
mean hydropathy-0.33
half-lifenot characterised
delivery routeintravenous
PubChem CID172198
PDBnot characterised
UniProt parentP01019

Mechanism

AT1/AT2 receptor agonist; the effector peptide of the renin-angiotensin system.

Reported targets: AT1R AT2R

Experimental structure

No experimental structure of this peptide is deposited in the PDB. Nothing is rendered here — a predicted fold would not be a structure, and this site does not draw one.

Position in the parent protein

exact match at residues 25–32 of Angiotensinogen (476 aa)

MAPAGVSLRATILCLLAWAGLAAGDRVYIHPFHLVIHNESTCEQLAKANAGKPKDP…

Parent sequence from UniProt P01019. Produced from angiotensin I by ACE cleavage.

Reported effects

Each row is an outcome described in the literature indexed for this peptide. Reported in the cited work — not a claim, not a recommendation.

Reported observations and the corpus they are drawn from.
reported outcomewhere it appears
vasoconstrictionEarly hemodynamic response to angiotensin II defines a prognostic phenotype … Journal of critical care 2026
aldosterone releaseEffects of esaxerenone add-on therapy versus angiotensin II receptor blocker… Journal of diabetes investigation 2026

Registered trials

Records from ClinicalTrials.gov. Listed for reference — this project sponsors no trial and is not involved in any of them.
NCTtitlestatusphase
NCT04715568Secondhand Tobacco Smoke and Cardiovascular DiseaseRECRUITINGPHASE4
NCT04331574Renin-Angiotensin System Inhibitors and COVID-19UNKNOWN
NCT00528385Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone SysCOMPLETEDNA
NCT02648243Impact of a Pharmacist-delivered Discharge and Follow-up Intervention for Patients With AcutCOMPLETEDNA
NCT01377285Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease UNKNOWNPHASE4

Literature (8)

Early hemodynamic response to angiotensin II defines a prognostic phenotype in bloodstream infection-associated septic shock — Journal of critical care 2026

abstract not reproduced — this record is not open-access, so it is linked rather than copied.

publisher record ↗ · PMID 42594819 · DOI 10.1016/j.jcrc.2026.155708

Effects of esaxerenone add-on therapy versus angiotensin II receptor blocker dose escalation on albuminuria and blood pressure in hypertensive patients with type 2 diabetes: An exploratory randomized study — Journal of diabetes investigation 2026

abstract not reproduced — this record is not open-access, so it is linked rather than copied.

publisher record ↗ · PMID 42555195 · DOI 10.1111/jdi.70412

Angiotensin II in the treatment of distributive shock and identification of clinical profiles with greater therapeutic benefit — Revista espanola de anestesiologia y reanimacion 2026

abstract not reproduced — this record is not open-access, so it is linked rather than copied.

publisher record ↗ · PMID 42061711 · DOI 10.1016/j.redare.2026.502116

The role of kir4.1/Kir5.1 in mediating the effect of angiotensin-II on Na-Cl-cotransporter — Current opinion in nephrology and hypertension 2026

abstract not reproduced — this record is not open-access, so it is linked rather than copied.

publisher record ↗ · PMID 42261750 · DOI 10.1097/mnh.0000000000001203

Angiotensin II and angiotensin-(1-7) neurotransmissions in the medial amygdala differently control cardiovascular and anxiogenic-like responses to stress in rats — Journal of psychopharmacology (Oxford, England) 2026

abstract not reproduced — this record is not open-access, so it is linked rather than copied.

publisher record ↗ · PMID 42343879 · DOI 10.1177/02698811261453873

Angiotensin-(1-7) suppresses pyroptosis in cerebral endothelium to decrease blood-brain barrier permeability and cognitive impairments in sepsis — The Journal of international medical research 2026

ObjectiveThis study aimed to explore the influence of the angiotensin-(1-7)/Mas receptor and angiotensin II/angiotensin II type 1 receptor pathways on pyroptosis during sepsis and their subsequent effects on cognitive function.MethodsAdult C57BL/6 mice were subjected to cecal ligation and puncture to induce sepsis. Brain microvascular endothelial cells were treated with angiotensin II and angiotensin-(1-7) to evaluate their impact on pyroptotic processes. Cognitive performance was assessed using the Morris water maze method, and blood-brain barrier permeability was quantified using Evans blue staining.ResultsCompared with the sham group, sepsis induced sustained activation of the angiotensin II/angiotensin II type 1 receptor pathway, whereas the angiotensin-(1-7)/Mas receptor pathway was progressively suppressed. Genetic ablation of cysteine-dependent aspartate protease-1 significantly a…

open access ↗ · PMID 42055817 · DOI 10.1177/03000605261437974

Angiotensin-converting enzyme inhibitors show an edge over angiotensin II receptor blockers in cardiovascular outcomes — European heart journal open 2026

abstract not reproduced — this record is not open-access, so it is linked rather than copied.

publisher record ↗ · PMID 42524189 · DOI 10.1093/ehjopen/oeag118

Angiotensin II Receptor Signaling in the Hypothalamic-Pituitary-Adrenal Axis and Spleen After Spinal Cord Injury Depends on the Sympathetic Innervation Integrity — Cellular and molecular neurobiology 2026

abstract not reproduced — this record is not open-access, so it is linked rather than copied.

publisher record ↗ · PMID 42250115 · DOI 10.1007/s10571-026-01760-4

Related

Glucagon

hormone · 8 citations

Ghrelin

hormone · 8 citations

Oxytocin

hormone · 8 citations

Vasopressin

hormone · 8 citations

Gonadorelin

hormone · 8 citations

Kisspeptin-10

hormone · 8 citations